Netherton Syndrome Clinical Trials
23 clinical trials for Netherton Syndrome across international registries, including 6 currently recruiting participants. Compare status, phase, eligibility criteria and locations.
- Study of Skin and Gut Microbiome in a Skin Condition Involving Skin Barrier Impairment and Allergic Symptoms: Netherton Syndrome — RECRUITING
- A Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of BCX17725 — RECRUITING · PHASE1
- Defining the Skin and Blood Biomarkers of Ichthyosis — RECRUITING
- Phase 2/3 Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome — RECRUITING · PHASE2
- Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome — RECRUITING · PHASE2
- Open Label, Safety and Efficacy Study of QRX003 Lotion in Subjects With Netherton Syndrome — RECRUITING · PHASE2
- A clinical trial to study the effects of genetically modified patients' skin stem cells — COMPLETED · PHASE1
- Evaluation of Topical ATR12-351 in Adults With Netherton Syndrome — COMPLETED · PHASE1
- Natural History of Netherton Syndrome — TERMINATED
- A PHASE 1/1B STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND IMMUNOGENICITY OF SINGLE AND MULTIPLE ASCENDING DOSES OF BCX17725 IN HEALTHY PARTICIPANTS AND MULTIPLE DOSES OF BCX17725 IN PARTICIPANTS WITH NETHERTON SYNDROME — TERMINATED · PHASE2
- A Study to Explore Safety, Pharmacokinetics, and Early Clinical Signal of Efficacy of DS-2325a in Patients With Netherton Syndrome — TERMINATED · PHASE1
- Clinical Trial Using Humira in Netherton Syndrome — COMPLETED · PHASE2
- Safety, Tolerability and Efficacy of QRX003 Lotion in Subjects With Netherton Syndrome — ACTIVE_NOT_RECRUITING · PHASE2
- A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Netherton Syndrome — TERMINATED · PHASE2
- A Study to Evaluate Topically Applied SXR1096 Cream in Patients With Netherton Syndrome — COMPLETED · PHASE1
- Natural History and Biological Study of Netherton Syndrome — COMPLETED · NA
- A Pilot Study of the Efficacy and Safety of Dupilumab Versus Placebo in Patients With Netherton Syndrome — OTHER · PHASE2
- A Study to Assess the Safety and Pharmacokinetics of Multiple Ascending Subcutaneous Doses of DS-2325a in Healthy Subjects — COMPLETED · PHASE1
- A Study to Assess the Safety and Pharmacokinetics of Single Ascending Subcutaneous and Intravenous Doses of DS-2325a in Healthy Subjects — COMPLETED · PHASE1
- The Efficacy and Safety of Secukinumab in Patients With Ichthyoses — COMPLETED · PHASE2
- A Study Evaluating the Safety and Efficacy of Topical BPR277 for the Treatment of Atopic Dermatitis and Netherton Syndrome — COMPLETED · PHASE1
- Safety Study of Elidel (Pimecrolimus) 1% Cream to Treat Netherton Syndrome — COMPLETED · PHASE1
- Gene Therapy for Netherton Syndrome — OTHER · PHASE1
Refine this search